315 results on '"Laoui, Damya"'
Search Results
2. A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages
3. CO-DELIVERY of glutamic acid-extended peptide antigen and imidazoquinoline TLR7/8 agonist via ionizable lipid nanoparticles induces protective anti-tumor immunity
4. Peroxiredoxin-1 is an H2O2 safe-guard antioxidant and signalling enzyme in M1 macrophages
5. Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop
6. Macrophages are metabolically heterogeneous within the tumor microenvironment
7. Monocytic myeloid-derived suppressor cells home to tumor-draining lymph nodes via CCR2 and locally modulate the immune response
8. Heterogeneity and function of macrophages in the breast during homeostasis and cancer
9. TIM3 Checkpoint Inhibition Fails to Prolong Survival in Ovarian Cancer-Bearing Mice
10. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling
11. Myeloid cell heterogeneity in cancer: not a single cell alike
12. Clinical Translation of [68Ga]Ga-NOTA-anti-MMR-sdAb for PET/CT Imaging of Protumorigenic Macrophages
13. Hapten/Myristoyl Functionalized Poly(propyleneimine) Dendrimers as Potent Cell Surface Recruiters of Antibodies for Mediating Innate Immune Killing
14. #479 The potential of anti-TIM3 in an ovarian cancer mouse model
15. Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models
16. Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment
17. Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
18. Data from IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D
19. Supplementary Figures 1-11 from IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D
20. Supplementary Figure from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
21. Supplementary Data from Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages
22. Data from Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
23. Supplementary Figures 1 through 5 from Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population
24. Data from Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population
25. Supplementary Methods from Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
26. Data from Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
27. Supplementary Tables 1-5 from Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
28. Supplementary Video 3 from Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
29. Supplementary Video 2 from Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
30. Supplementary Figures S1-S9 from M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment
31. Supplementary Video 1 from Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
32. Supplementary Methods from M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment
33. Supplementary Figures 1-8, Video Legends 1-3 from Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
34. Supplementary Tables S1-S2 from M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment
35. Supplementary Tables 1 and 2 from Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population
36. Supplementary Materials, Tables 1-4, Figures 1-10 from Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
37. Supplementary Methods from Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population
38. Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop
39. Peroxiredoxin-1 is an H2o2 Safe-Guard Antioxidant and Signalling Enzyme in Macrophages Independent of Their Polarization State
40. The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology
41. Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment
42. Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression
43. Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
44. Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
45. Modulation of CD8+ T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells
46. Beyond the M‐CSF receptor – novel therapeutic targets in tumor‐associated macrophages
47. CCR2-dependent monocyte-derived macrophages resolve inflammation and restore gut motility in postoperative ileus
48. Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models.
49. Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancer
50. Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.